Clik here to view.
Exelixis与武田签署在日本进行新型抗癌药Cabozantinib商品化和开发的排他性授权协议
加州南圣弗朗西斯科和马萨诸塞州剑桥和日本大阪 (美国商业资讯) — Exelixis, Inc....
View ArticleClik here to view.
Lombard Medical Announces Successful Completion of First 15 Cases in Japan...
OXFORDSHIRE, England Lombard Medical, Inc. (NASDAQ: EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs), today announced that...
View ArticleClik here to view.
Acelity Announces Debt Reduction with Proceeds from Sale of LifeCell Business...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care company, today announced that, on February 3, 2017, its wholly-owned operating subsidiaries, Kinetic Concepts, Inc. and KCI...
View ArticleClik here to view.
Vyome Biosciences Announces Top-Line Results from Phase 1 Study of VB-1953...
NEW DELHI Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced top-line data from...
View ArticleClik here to view.
Masimo宣布在Root®患者监测和互通平台上添加早期预警评分
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天宣布，Root®患者监测和互通平台上的早期预警评分(EWS)限量上市。EWS可累积来自于多项生命体征和临床观察的信息，生成一个代表患者恶化潜在程度的评分。 Root可以与Radical-7®或Radius-7®脉搏碳氧氧饱和度仪®和Masimo Open Connect™...
View ArticleClik here to view.
患者安全运动在第5届年度峰会上宣布创新奖获奖者
加州达纳点 (美国商业资讯) — 第5届年度世界患者安全与科技峰会宣布了今年的创新奖获奖者。该年度峰会汇聚了数百位医学专业人员、医院管理者、医学技术经理人和患者维权人士，以讨论将帮助杜绝每年美国医院里发生的20多万例、全世界数百万例可预防死亡中的挑战、创新流程和操作。...
View ArticleClik here to view.
松下与联华电子公司合作开发新一代可变电阻式存储器批量生产工艺
日本大阪 (美国商业资讯)–松下电器半导体有限公司（“PSCS”，总部：日本京都府长冈京市；总裁： Kazuhiro Koyama）已与联华电子公司（“UMC”，总部：台湾新竹市；首席执行官：颜博文）达成一项协议，双方将合作开发新一代40nm 可变电阻式存储器(ReRAM)[1]的批量生产工艺。...
View ArticleClik here to view.
Takeda Presents $1 Million Gift to the Koch Institute for Integrative Cancer...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE:4502) and the Koch Institute for Integrative Cancer Research at MIT today jointly announced that Takeda will support...
View ArticleClik here to view.
トーマス・クエニが事務局長としてIFPMAのかじを取る
ジュネーブ （ビジネスワイヤ） — トーマス・B・クエニが2月1日にIFPMA（国際製薬団体連合会）の事務局長に就任し、研究型バイオ医薬品業界の利益を世界レベルで代表します。...
View ArticleClik here to view.
WIN 2017研讨会加快全球精准癌症医学的创新
法国维勒瑞夫 (美国商业资讯) — WIN 2017研讨会将于2017年6月26-27日在法国巴黎召开。CME认证的WIN2017是一次异乎寻常的科学活动，致力于面向所有癌症医护专业人员“加快全球精准癌症医学的创新”。 Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View ArticleClik here to view.
Clik here to view.
Cook Medical Australia Invests in the Future with New Commercialisation Centre
BRISBANE, Australia Medical device manufacturer Cook Medical Australia has officially opened a new commercialisation and development centre in Brisbane, designed to assist businesses, entrepreneurs...
View ArticleClik here to view.
Replicor Discloses Updated REP 401 Clinical Data at APASL 2017
MONTREAL Replicor Inc., a privately held biopharmaceutical company targeting a cure for chronic hepatitis B and D patients, today announced that an updated interim analysis from its latest REP 401...
View ArticleClik here to view.
Acelity Announces Debt Reduction with Proceeds from Sale of LifeCell Business...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care company, today announced that, on February 3, 2017, its wholly-owned operating subsidiaries, Kinetic Concepts, Inc. and KCI...
View ArticleClik here to view.
Vyome Biosciences Announces Top-Line Results from Phase 1 Study of VB-1953...
NEW DELHI Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announced top-line data from...
View ArticleClik here to view.
精密がん治療におけるグローバルイノベーションを促進する WIN 2017シンポジウム
仏ビルジュイフ （ビジネスワイヤ） — WIN 2017シンポジウムが2017年6月26～27日にフランスのパリで開催されます。CMEは、WIN2017ががんケアのすべての専門家を対象とし、「精密がん治療におけるグローバルイノベーションの促進」に専心する格別の科学イベントであると認定しました。 このSmart News...
View ArticleClik here to view.
NICE Guidance Recommends HeartFlow FFRct Analysis to Help Determine Cause of...
REDWOOD CITY, Calif. The National Institute for Health and Care Excellence (NICE) in the United Kingdom issued guidance today for use of the HeartFlow® FFRct Analysis to help determine the cause of...
View ArticleClik here to view.
Replicor在APASL 2017上披露更新版REP 401临床数据
蒙特利尔 (美国商业资讯) — Replicor Inc.是一家私营生物制药公司，致力于根治慢性乙型肝炎和慢性丁型肝炎，该公司今天宣布，其最新REP 401临床试验的中期分析更新已入选亚太区肝脏研究学会(APASL)年会的口述呈报，APASL将于2017年2月15-19日在中国上海召开。 REP...
View ArticleClik here to view.
Chi-Med and AstraZeneca Present Savolitinib Papillary Renal Cell Carcinoma...
LONDON Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) and AstraZeneca PLC (“AstraZeneca”) will present data from the ongoing Phase II clinical trial of savolitinib in patients with...
View ArticleClik here to view.
Aurinia Announces Results from Japanese Phase I Ethnic Bridging Study for...
VICTORIA, British Columbia Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”), a clinical stage biopharmaceutical company focused on the global immunology market,...
View Article